India has the capacity and tie-ups to manufacture about 2 billion vaccine doses but its strategy to bank only on local production and not enter into any pre-purchase agreements with multiple global drugmakers could delay the availability of vaccines in the country.from Industry-Economic Times
Read The Rest:economictimes...